LOX and cancer: LOX-mediated cross-linking of collagen IV recruits CD11b+ BMDC to the metastatic niche in the lungs (107, 109), and these CD11b+ cells further remodel the ECM into a favorable home for extravasating cancer cells, e.g., by laying down the proteoglycan versican (Figure 5) (116).